Glaucoma

Autor: Jost B Jonas, Tin Aung, Rupert R Bourne, Alain M Bron, Robert Ritch, Songhomitra Panda-Jonas

Publikováno v: The Lancet
The Lancet, Elsevier, 2017, ⟨10.1016/S0140-6736(17)31469-1⟩
The Lancet, Elsevier, 2017, 390 (10108), pp.2183-2193. ⟨10.1016/S0140-6736(17)31469-1⟩

International audience; Glaucoma is a heterogeneous group of diseases characterised by cupping of the optic nerve head and visual-field damage. It is the most frequent cause of irreversible blindness worldwide. Progression usually stops if the intrao

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29cd57c94f7981232a9c3ff5ade40293
https://pubmed.ncbi.nlm.nih.gov/29486943

National Eye Institute's (NEI) coordination efforts and current opportunities for sustainability, adaptation, and climate resilience in global eye health - ARVO 2023 session commentary.

Autor: McCance E; Department of Ophthalmology, Royal Glamorgan Hospital, Llantrisant, UK. elliemccance@gmail.com., Taylor HR; Melbourne School of Population and Global Health, Melbourne, VIC, Australia., Acharya NR; Departments of Ophthalmology and Epidemiology, University of California, San Francisco, USA., Thiel CL; Department of Population Health & Ophthalmology, New York University, New York, NY, USA., Resnikoff S; School of Optometry and Vision Sciences, University of New South Wales, Sydney, NSW, Australia., Bourne R; Cambridge Eye Research Centre, Addenbrookes Hospital, Cambridge, UK.

Publikováno v: Eye (London, England) [Eye (Lond)] 2024 Aug; Vol. 38 (11), pp. 1984-1985. Date of Electronic Publication: 2023 Nov 30.

A validated web-application (GFDC) for automatic classification of glaucomatous visual field defects using Hodapp-Parrish-Anderson criteria.

Autor: Thirunavukarasu AJ; University of Cambridge School of Clinical Medicine, University of Cambridge, Cambridge, UK. ajt205@cantab.ac.uk.; Oxford University Clinical Academic Graduate School, University of Oxford, Oxford, UK. ajt205@cantab.ac.uk.; Cambridge Eye Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. ajt205@cantab.ac.uk.; Oxford University Hospitals NHS Foundation Trust, Oxford, UK. ajt205@cantab.ac.uk., Jain N; Cambridge Eye Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Bedfordshire Hospitals NHS Foundation Trust, Luton, UK., Sanghera R; University of Cambridge School of Clinical Medicine, University of Cambridge, Cambridge, UK.; Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Lattuada F; Department of Engineering, University of Cambridge, Cambridge, UK., Mahmood S; University of Cambridge School of Clinical Medicine, University of Cambridge, Cambridge, UK., Economou A; University of Cambridge School of Clinical Medicine, University of Cambridge, Cambridge, UK., Yu HCY; Cambridge Eye Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; University of New South Wales, Sydney, Australia., Bourne R; Cambridge Eye Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. rupert.bourne1@nhs.net.; Vision & Eye Research Institute, School of Medicine, Anglia Ruskin University, Cambridge, UK. rupert.bourne1@nhs.net.

Publikováno v: NPJ digital medicine [NPJ Digit Med] 2024 May 18; Vol. 7 (1), pp. 131. Date of Electronic Publication: 2024 May 18.

Confusion around Certification of Vision Impairment (CVI) and registration processes-are patients falling through the cracks?

Autor: Pardhan S; Vision and Eye Research Institute, Anglia Ruskin University, Cambridge, UK. shahina.pardhan@aru.ac.uk., Driscoll R; Vision and Eye Research Institute, Anglia Ruskin University, Cambridge, UK., Ingleton H; Royal National Institute of Blind People, London, UK., Slade J; Royal National Institute of Blind People, London, UK., Bowen M; College of Optometrists, London, UK., Lovell-Patel R; NHS England and NHS Improvement, Cambridge, UK., Farrell S; Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, UK., Bourne R; Vision and Eye Research Institute, Anglia Ruskin University, Cambridge, UK., Mahoney S; Department of Information Studies, University College London, London, UK., Ahluwalia S; School of Medicine, Anglia Ruskin University, Cambridge, UK., Trott M; Vision and Eye Research Institute, Anglia Ruskin University, Cambridge, UK.; Centre for Public Health, Queen's University Belfast, Belfast, UK.

Publikováno v: Eye (London, England) [Eye (Lond)] 2023 Nov; Vol. 37 (16), pp. 3412-3416. Date of Electronic Publication: 2023 Apr 19.

Finger-Prick Autologous Blood (FAB) Eye Drops for Dry Eye Disease: Single Masked Multi-Centre Randomised Controlled Trial.

Autor: Hassan A; Department of External Eye Diseases, Moorfields Eye Hospital, London, UK.; Department of Ophthalmology, UCL Institute of Ophthalmology, London, UK., Balal S; Department of External Eye Diseases, Moorfields Eye Hospital, London, UK.; Department of Ophthalmology, UCL Institute of Ophthalmology, London, UK., Cook E; Department of Healthcare, University of Bedfordshire, Luton, UK., Dehbi HM; Trials department, Comprehensive Clinical Trials Unit, London, UK., Pardhan S; Department of Eye Research, Vision and Eye Research Institute (VERI) Anglia Ruskin University, Cambridge, UK., Bourne R; Department of Ophthalmology, Addenbrookes Hospital, Cambridge, UK., Ahmad S; Department of External Eye Diseases, Moorfields Eye Hospital, London, UK.; Department of Ophthalmology, UCL Institute of Ophthalmology, London, UK., Sharma A; Department of External Eye Diseases, Moorfields Eye Hospital, London, UK.; Department of Ophthalmology, UCL Institute of Ophthalmology, London, UK.

Publikováno v: Clinical ophthalmology (Auckland, N.Z.) [Clin Ophthalmol] 2022 Dec 02; Vol. 16, pp. 3973-3979. Date of Electronic Publication: 2022 Dec 02 (Print Publication: 2022).